Cdk5 Drives Formation of Heterogeneous Pancreatic Neuroendocrine Tumors

Scientists reported development of an inducible, conditional mouse model of PanNETs by using a bi-transgenic system for regulated expression of the aberrant activator of Cdk5, p25, specifically in β-islet cells.